https://www.ndtvprofit.com/business/nektar-s-waning-response-rates-with-drug-combo-raises-concerns?utm_source=telegram&utm_medium=referral&utm_campaign=socialshare
Nektar Plummets Amid Concern Over Cancer-Drug Trial Results